Kantele, Anu |
NCT06104345: Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines |
|
|
| Recruiting | 4 | 60 | Europe | Oral typhoid fever vaccine, Vivotif®, Oral cholera vaccine, Dukoral® | Helsinki University Central Hospital, University of Helsinki | Vaccine-Preventable Diseases, Typhoid Fever, Cholera | 12/25 | 12/25 | | |
| Active, not recruiting | 2 | 390 | Europe | Convalescent plasma from COVID-19 donors, Placebo | Helsinki University Central Hospital, Finnish Red Cross | Covid19 | 01/22 | 01/23 | | |
Pakkanen, Sari |
NCT06104345: Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines |
|
|
| Recruiting | 4 | 60 | Europe | Oral typhoid fever vaccine, Vivotif®, Oral cholera vaccine, Dukoral® | Helsinki University Central Hospital, University of Helsinki | Vaccine-Preventable Diseases, Typhoid Fever, Cholera | 12/25 | 12/25 | | |
FMT-UTI, NCT06050148: Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections |
|
|
| Recruiting | 2/3 | 100 | Europe | Feacal microbial transplantation (FMT), Placebo transplantation (PT) | Helsinki University Central Hospital, University of Helsinki | Recurrent Urinary Tract Infection | 12/28 | 12/29 | | |
Riekkinen, Marianna |
NCT06104345: Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines |
|
|
| Recruiting | 4 | 60 | Europe | Oral typhoid fever vaccine, Vivotif®, Oral cholera vaccine, Dukoral® | Helsinki University Central Hospital, University of Helsinki | Vaccine-Preventable Diseases, Typhoid Fever, Cholera | 12/25 | 12/25 | | |